| Aplastic Anemia and MDS International Foundation

March for Marrow 5K Run & Walk Washington, DC

Get involved and give back by joining the March for Marrow 5K Run & Walk Washington, DC!  REGISTER NOW.

The event will be held on Saturday, December 10 at East Potomac Park/Hains Point in Washington, DC.  The 5K Run will begin at 7:00 am.  In addition to the 5K, the March for Marrow Walk will also be held at 7:30 am.

Event Date: 
Sat, 12/10/2016 -
6:00am to 9:15am
Community Event Type: 

Genetic Mutations for AML found Years before Diagnosis

 Patients with acute myeloid leukemia (AML) may have genetic mutations in their blood indicating they are at high risk of developing the disease about nine years before diagnosis, according to research from Weill Cornell Medicine and NewYork-Presbyterian investigators. They presented their findings at the 59th annual American Society of Hematology meeting on Dec. 10 in Atlanta, Ga. Full article here

Combined intensive immunosuppression and eculizumab for aplastic anemia in the context of hemolytic paroxysmal nocturnal hemoglobinuria: a retrospective analysis

Author(s): 
Pagliuca S, Risitano AM, De Fontbrune FS, Robin M, Iori AP, Marotta S, Michonneau D, Villate A, Desmier D, Socié G, De Latour RP
Primary Author: 
Pagliuca S
Journal Title: 
Bone Marrow Transplant
Original Publication Date: 
Nov 2017

No abstract available.

Bone Marrow Diseases: 

Next-Generation Gene Sequencing Differentiates Hypoplastic Myelodysplastic Syndrome from Aplastic Anemia

Author(s): 
Lew JL, Fenderson JL, Carmichael MG
Primary Author: 
Lew JL
Journal Title: 
Hawaii J Med Public Health
Original Publication Date: 
Nov 2017

Hypoplastic Myelodysplastic Syndrome (h-MDS) comprises 15% of all MDS and has traditionally been difficult to distinguish from

Bone Marrow Diseases: